STOCK TITAN

Altimmune to Participate at Leerink Partners Therapeutics Forum

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Altimmune (Nasdaq: ALT), a clinical-stage biopharmaceutical company, announced its participation in the Leerink Partners Therapeutics Forum on July 9 and 10, 2024, in Boston, MA. The company's management team will engage in one-on-one meetings with institutional investors. This forum will include panel discussions with leading physicians focusing on autoimmune and metabolic diseases. Altimmune aims to leverage these interactions to advance its strategic objectives and investor relations.

Positive
  • None.
Negative
  • None.

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be hosting one-on-one meetings with institutional investors at the Leerink Partners Therapeutics Forum: I&I and Metabolism, being held on July 9 and 10, 2024 in Boston, MA. The event will feature analyst-hosted panel discussions with leading physicians in a range of autoimmune and metabolic indications, as well as meetings between participating companies and investors.

About Altimmune

Altimmune is a clinical-stage biopharmaceutical company focused on developing innovative next-generation peptide-based therapeutics. The Company is developing pemvidutide, a GLP-1/glucagon dual receptor agonist for the treatment of obesity and MASH. For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Company Contact:
Vipin Garg
President and Chief Executive Officer
Phone: 240-654-1450
ir@altimmune.com

Investor Contacts:
Lee Roth
Burns McClellan
Phone: 646-382-3403
lroth@burnsmc.com

Julia Weilman
Burns McClellan
Phone: 646-732-4443
jweilman@burnsmc.com

Media Contact:
Danielle Cantey
Inizio Evoke, Biotech
Phone: 619-826-4657
Danielle.cantey@inizioevoke.com


FAQ

What is the date of Altimmune's participation in the Leerink Partners Therapeutics Forum?

Altimmune will participate in the Leerink Partners Therapeutics Forum on July 9 and 10, 2024.

What will Altimmune's management team do at the Leerink Partners Therapeutics Forum?

Altimmune's management team will host one-on-one meetings with institutional investors.

Where is the Leerink Partners Therapeutics Forum being held?

The Leerink Partners Therapeutics Forum is being held in Boston, MA.

What topics will be discussed at the Leerink Partners Therapeutics Forum?

The forum will feature panel discussions on autoimmune and metabolic diseases.

What is the stock symbol for Altimmune?

The stock symbol for Altimmune is ALT.

Altimmune, Inc.

NASDAQ:ALT

ALT Rankings

ALT Latest News

ALT Stock Data

585.35M
70.56M
0.79%
56.57%
32.27%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
GAITHERSBURG